Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.

Evers NM, van de Klundert TM, van Aesch YM, Wang S, de Roos WK, Romano A, de Haan LH, Murk AJ, Ederveen AG, Rietjens IM, Groten JP.

Toxicol In Vitro. 2013 Sep;27(6):1753-61. doi: 10.1016/j.tiv.2013.04.014. Epub 2013 May 13.

PMID:
23680332
2.

Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein.

Sotoca AM, Gelpke MD, Boeren S, Ström A, Gustafsson JÅ, Murk AJ, Rietjens IM, Vervoort J.

Mol Cell Proteomics. 2011 Jan;10(1):M110.002170. doi: 10.1074/mcp.M110.002170. Epub 2010 Sep 30.

3.

Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.

Sotoca AM, van den Berg H, Vervoort J, van der Saag P, Ström A, Gustafsson JA, Rietjens I, Murk AJ.

Toxicol Sci. 2008 Oct;105(2):303-11. doi: 10.1093/toxsci/kfn141. Epub 2008 Jul 21.

4.

Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.

Cotrim CZ, Fabris V, Doria ML, Lindberg K, Gustafsson JÅ, Amado F, Lanari C, Helguero LA.

Oncogene. 2013 May 9;32(19):2390-402. doi: 10.1038/onc.2012.261. Epub 2012 Jul 2.

PMID:
22751110
5.

Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.

Nadal-Serrano M, Pons DG, Sastre-Serra J, Blanquer-Rosselló Mdel M, Roca P, Oliver J.

Int J Biochem Cell Biol. 2013 Sep;45(9):2045-51. doi: 10.1016/j.biocel.2013.07.002. Epub 2013 Jul 17.

PMID:
23871935
6.

The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblasts.

Palmieri C, Saji S, Sakaguchi H, Cheng G, Sunters A, O'Hare MJ, Warner M, Gustafsson JA, Coombes RC, Lam EW.

J Mol Endocrinol. 2004 Aug;33(1):35-50.

7.

The effects of 17β-estradiol on mitochondrial biogenesis and function in breast cancer cell lines are dependent on the ERα/ERβ ratio.

Sastre-Serra J, Nadal-Serrano M, Pons DG, Valle A, Oliver J, Roca P.

Cell Physiol Biochem. 2012;29(1-2):261-8. doi: 10.1159/000337607. Epub 2012 Mar 1.

8.

Genistein modulates proliferation and mitochondrial functionality in breast cancer cells depending on ERalpha/ERbeta ratio.

Pons DG, Nadal-Serrano M, Blanquer-Rossello MM, Sastre-Serra J, Oliver J, Roca P.

J Cell Biochem. 2014 May;115(5):949-58. doi: 10.1002/jcb.24737.

PMID:
24375531
9.

A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.

Williams C, Edvardsson K, Lewandowski SA, Ström A, Gustafsson JA.

Oncogene. 2008 Feb 7;27(7):1019-32. Epub 2007 Aug 13.

PMID:
17700529
11.

Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.

Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.

Int J Oncol. 2005 Aug;27(2):327-35.

PMID:
16010412
12.

Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.

Sotoca AM, Ratman D, van der Saag P, Ström A, Gustafsson JA, Vervoort J, Rietjens IM, Murk AJ.

J Steroid Biochem Mol Biol. 2008 Dec;112(4-5):171-8. doi: 10.1016/j.jsbmb.2008.10.002. Epub 2008 Oct 8.

PMID:
18955141
13.

Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.

Sundar SN, Kerekatte V, Equinozio CN, Doan VB, Bjeldanes LF, Firestone GL.

Mol Endocrinol. 2006 Dec;20(12):3070-82. Epub 2006 Aug 10.

PMID:
16901971
14.

Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.

Jonsson P, Katchy A, Williams C.

Endocr Relat Cancer. 2014 Jan 30;21(2):143-60. doi: 10.1530/ERC-13-0444. Print 2014 Apr.

15.

Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.

Jarzabek K, Koda M, Kozlowski L, Mittre H, Sulkowski S, Kottler ML, Wolczynski S.

Eur J Cancer. 2005 Dec;41(18):2924-34. Epub 2005 Nov 10.

PMID:
16289616
16.

Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.

Li W, Jia M, Qin X, Hu J, Zhang X, Zhou G.

FEBS J. 2013 Dec;280(23):6128-40. doi: 10.1111/febs.12533. Epub 2013 Oct 8.

17.

Proliferation assays for estrogenicity testing with high predictive value for the in vivo uterotrophic effect.

Wang S, Aarts JM, Evers NM, Peijnenburg AA, Rietjens IM, Bovee TF.

J Steroid Biochem Mol Biol. 2012 Feb;128(3-5):98-106. doi: 10.1016/j.jsbmb.2011.11.009. Epub 2011 Nov 25.

PMID:
22138011
18.

The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.

Pons DG, Torrens-Mas M, Nadal-Serrano M, Sastre-Serra J, Roca P, Oliver J.

Int J Biochem Cell Biol. 2015 Sep;66:85-94. doi: 10.1016/j.biocel.2015.07.014. Epub 2015 Jul 29.

PMID:
26232188
19.
20.

The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.

Nadal-Serrano M, Sastre-Serra J, Pons DG, Miró AM, Oliver J, Roca P.

J Cell Biochem. 2012 Oct;113(10):3178-85. doi: 10.1002/jcb.24192.

PMID:
22615145
Items per page

Supplemental Content

Write to the Help Desk